Page last updated: 2024-08-22

cupric chloride and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

cupric chloride has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mueck, AO; Seeger, H; Wallwiener, D1

Other Studies

1 other study(ies) available for cupric chloride and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

ArticleYear
Fluvastatin combined with 17beta-estradiol: effect on the oxidation of human low density lipoprotein.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2000, Volume: 108, Issue:4

    Topics: Copper; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Indoles; Lipoproteins, LDL; Osmolar Concentration; Time Factors

2000